#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4379617	F	Antiproliferative activity against human GIST430 cells harboring c-KIT exon 11 primary in-frame V560-L576 deletion mutant and exon 13 heterozygous secondary missense V654A mutant assessed as cell growth inhibition after 120 hrs by methylene blue staining based assay	Homo sapiens	4	ALA4376836	cell-based format	Scientific Literature
2.	ALA4379667	F	Antitumor activity against human GIST430 cells xenografted in NOD/SCID mouse assessed as tumor regression at 30 mg/kg, po qd administered on day 1,2,5 to 9 and 12 to 16 measured after 30 days by digital caliper method relative to control	Homo sapiens	1	ALA4376836	organism-based format	Scientific Literature
3.	ALA4379668	F	Antitumor activity against human GIST430 cells xenografted in NOD/SCID mouse assessed as decrease in tumor regrowth at 30 mg/kg, po qd administered on day 1,2,5 to 9 and 12 to 16 measured after 30 days by digital caliper method	Homo sapiens	1	ALA4376836	organism-based format	Scientific Literature
4.	ALA4379669	F	Antitumor activity against human GIST430 cells xenografted in NOD/SCID mouse assessed as decrease in tumor regrowth at 80 mg/kg, po qd administered on day 1,2,5 to 9 and 12 to 16 measured after 30 days by digital caliper method	Homo sapiens	1	ALA4376836	organism-based format	Scientific Literature
5.	ALA4379670	F	Antitumor activity against human GIST430 cells xenografted in NOD/SCID mouse assessed as tumor regression at 15 mg/kg, po qd administered on day 1,2,5 to 9 and 12 to 16 measured after 30 days by digital caliper method	Homo sapiens	1	ALA4376836	organism-based format	Scientific Literature
6.	ALA4386482	F	Antitumor activity against human GIST430 cells harboring c-KIT exon 11 primary in-frame V560-L576 deletion mutant and exon 13 heterozygous secondary missense V654A mutant xenografted in NOD-SCID mouse assessed as reduction in tumor size at 25, po administered for 2 weeks with 2 days rest after day 5 and measured thrice per week up to 14 days during compound dosing relative to control	Homo sapiens	1	ALA4385613	organism-based format	Scientific Literature
7.	ALA4386483	F	Antitumor activity against human GIST430 cells harboring c-KIT exon 11 primary in-frame V560-L576 deletion mutant and exon 13 heterozygous secondary missense V654A mutant xenografted in NOD-SCID mouse assessed as tumor growth inhibition at 25 mg/kg, po administered for 2 weeks with 2 days rest after day 5 and measured thrice per week up to 21 days during compound dosing	Homo sapiens	1	ALA4385613	organism-based format	Scientific Literature
8.	ALA4386529	F	Antiproliferative activity against human GIST430 cells harboring c-KIT exon 11 primary in-frame V560-L576 deletion mutant and exon 13 heterozygous secondary missense V654A mutant assessed as reduction in cell viability by MTS assay	Homo sapiens	3	ALA4385613	cell-based format	Scientific Literature
9.	ALA4386530	F	Antiproliferative activity against human GIST430 cells harboring c-KIT exon 11 primary in-frame V560-L576 deletion mutant and exon 13 heterozygous secondary missense V654A mutant assessed as reduction in cell viability by methylene blue staining based assay	Homo sapiens	3	ALA4385613	cell-based format	Scientific Literature
10.	ALA4386542	F	Antitumor activity against human GIST430 cells harboring c-KIT exon 11 primary in-frame V560-L576 deletion mutant and exon 13 heterozygous secondary missense V654A mutant xenografted in NOD-SCID mouse assessed as tumor regression at 40 mg/kg, po administered for 2 weeks with 2 days rest after day 5 and measured thrice per week up to 21 days during compound dosing	Homo sapiens	1	ALA4385613	organism-based format	Scientific Literature
11.	ALA4386543	F	Antitumor activity against human GIST430 cells harboring c-KIT exon 11 primary in-frame V560-L576 deletion mutant and exon 13 heterozygous secondary missense V654A mutant xenografted in NOD-SCID mouse assessed as tumor growth inhibition at 40 mg/kg, po administered for 2 weeks with 2 days rest after day 5 and measured thrice per week up to 21 days during compound dosing	Homo sapiens	1	ALA4385613	organism-based format	Scientific Literature
12.	ALA4425253	F	Cytotoxicity against imatinib-resistant human GIST430 cells assessed as decrease in cell viability after 7 days by alamar blue assay	Homo sapiens	1	ALA4425084	cell-based format	Scientific Literature